Drug discovery combats ovarian cancerJune 5th, 2011 - 10:09 pm ICT by IANS
London, Jun 5 (IANS) A drug discovery can increase an ovarian cancer patients’ life expectancy by up to eight months — the biggest breakthrough in 20 years of its treatment.
British researchers found Avastin, which is used to treat breast and bowel cancers, is also effective against ovarian cancer.
The disease has been called the silent killer because it often has no symptoms in the early stages and in 80 percent of cases is not detected until it has spread. Currently, the only treatment is chemotherapy following surgery.
Annwen Jones, chief executive of the charity Target Ovarian Cancer, said: “It is the first glimmer of hope that there are significant advancements in treatments for ovarian cancer on the horizon.”
“There is a moral imperative to ensure Avastin is fast-tracked through the necessary regulatory processes,” the Daily Mail quoted him as saying.
The research involved more than 1,500 women across Europe with advanced ovarian cancer.
All had their tumours removed and received chemotherapy, but those who were also given Avastin, which starves tumours of the blood they need to grow and spread, lived on an average 7.8 months longer than the control group.
Lead investigator Charlie Gourley, from the Edinburgh Cancer Research Centre, said: “We would like to be able to make ovarian cancer a chronic, rather than fatal, disease.”
Roche, which manufactures the drug, has applied to the European Medicines Agency for a licence to use it to treat ovarian cancer, which means it could be available before the end of the year.
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- Avastin helps women who are suffering from ovarian cancer - Oct 12, 2010
- New drug may fight ovarian cancer - Jun 07, 2010
- Electric shocks soften up cancer cells for treatment - Dec 07, 2010
- How does cancer spread? - Dec 12, 2010
- Now, a jab that will halt the most deadly forms of cancer - Jul 12, 2010
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- New experimental drug slows down growth of ovarian cancer - Apr 16, 2011
- New drug hope for lung cancer sufferers - Mar 29, 2011
- Vaccine extends life of brain cancer patients - Apr 19, 2012
- Drug used to treat asthma 'prevents spread of breast cancer' - Nov 04, 2010
- Wonder drug could kill all types of cancer - Jun 27, 2011
- British 'smart bomb' to target cancer - Jun 30, 2012
- Gene makes ovarian cancer resistant to chemotherapy - Mar 03, 2011
- Study shows that a new experimental cancer drug delays breast tumor growth - Jun 05, 2012
Tags: avastin, british researchers, cancer research centre, chemotherapy, control group, daily mail, drug discovery, eight months, european medicines, first glimmer, glimmer of hope, gourley, medicines agency, moral imperative, ovarian cancer, ovarian cancer patients, regulatory processes, silent killer, target, tumours